埃奎利祖马布作为肌危机中的额外救援疗法
Francesco Crescenzo1, Mattia Zanoni1, Laura Ferigo1
1Neurology Unit, "Mater Salutis" Hospital, AULSS 9 Scaligera, 37045 Verona, Italy.
埃奎利祖马布在治疗严重泛性肌痛性肌痛症 (gMG) 患者中表现有前途,这些患者没有对其他治疗做出反应. 本案例研究强调了其在管理耐火性gMG的潜在好处,即使在肌危机中.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 一般化肌痛性肌痛症 (gMG) 是一种影响神经肌肉结合的自身免疫性疾病.
- 基于REGAIN试验,Eculizumab是一种C5补剂抑制剂,已被批准用于ACHR-Ab阳性耐火gMG (MGFAII-IV类).
- 在肌危机 (MGFA V) 中eculizumab的疗效在很大程度上仍未研究.
研究的目的:
- 报告一个患者使用eculizumab的病例,患者患有严重的,耐火的gMG和复发的肌危机.
- 为了评估eculizumab在患有骨髓质疏松症危机的患者的实际疗效.
主要方法:
- 一名73岁的男性患有AChR-Ab-阳性gMG,耐普得尼松和阿扎西奥普林的耐火性,接受了eculizumab的治疗.
- 患者经历了反复复发的临床恶化,需要输管.
- 治疗反应的评估是基于临床恢复.
主要成果:
- 患者在治疗eculizumab的15天内显示出显著的临床改善.
- 他被送出了维护eculizumab和逐渐减缓的类固醇治疗方案.
- 这个真实的案例表明,在严重的GMG恶化中,潜在的好处.
结论:
- 埃奎利祖马布可能为患有严重,耐火性GMG的患者提供好处,包括那些经历肌危机的患者.
- 事证据支持eculizumab在肌危机中的使用.
- 需要进一步的研究来证实eculizumab在肌危机中的有效性和安全性.
更多相关视频
08:38Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
Published on: April 9, 2012
07:52Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
相关概念视频
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Myocarditis III: Medical Management
Cardiopulmonary Resuscitation III: AED Use
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)